For instance, increased expression of RANK ligand (RANKL) in the RANKL/RANK pathway was associated with poor response of osteosarcoma patients to preoperative chemotherapy and lower cancer‐free survival 6, and specific inhibition of RANK only in osteoclasts abrogated osteosarcoma development 7. This evidence concerns the gene TNFSF11 and osteosarcoma.